Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa
Discussions are ongoing with the U.S. Food and Drug Administration regarding the approval of the vaccine regimen in the U.S. WHO Prequalification is often a prerequisite for national registrations of new vaccines and medicines in developing countries. Johnson &Johnson now looks forward to collaborating with the WHO’s African Vaccine Regulatory Forum (AVAREF) to progress national registrations of the Company’s Ebola vaccine regimen. The Company’s Ebola vaccine regimen is designed to be used proactively to induce immunity against Ebola virus disease in adults and children. Johnson &Johnson’s Commitment to Ebola &Pandemic PreparednessJohnson &Johnson is one of the few innovative healthcare companies in the world today that is actively advancing science across multiple disease areas with the aim of strengthening public health. We accelerated the development of our Ebola vaccine regimen in 2014 in response to the worst Ebola outbreak on record, which took place in West Africa from 2014-2016 and caused more than 11,000 deaths. In 2019, in response to the second-worst outbreak which took place 2018-2020 in the Democratic Republic of the Congo (DRC), Johnson &Johnson announced it would provide its Ebola vaccine regimen to assist immunization efforts in the affected region and in neighboring Rwanda through the UMURINZI vaccination campaign. This marked the first widespread deployment of Ebola vaccines in an outbreak setting. The Rwandan Mini...
Conclusions Our results confirm earlier prospective and retrospective data regarding the efficacy and importance of C/M-ECT as relapse prevention. After treatment discontinuation, close monitoring of early warning signs for relapse is crucial, especially in the first few months. With the COVID-19 pandemic continuing, our data provide an indication of the necessity to ensure adequate care and access to ECT not only for the acutely ill but also for the vulnerable patients who are depending on C/M-ECT.
No abstract available
While some clinicians were worried about the mandate, in the end, they're coping just fine.
Jeffrey A. SingerA Food and Drug Administration Advisory Panel justapproved, narrowly, the Merck antiviral drug Molnupiravir. This is just step one. We now have to wait for the FDA to decide on emergency use authorization.The U.K. approved Molnupiravir on November 4.Merck applied to the FDA for approval on October 11. Vaccines are the best long ‐term defense against COVID-19, but antivirals are the best first‐line defense, especially when new variants can develop that escape the immunity provided by vaccines.Rather than wait weeks for the vaccine to take effect, antivirals —like antibiotics—work immed...
West Virginia's coronavirus czar, West Virginia University's Dr. Clay Marsh, said Tuesday that the emergence of the new omicron variant of Covid-19 underscores the need for everyone to be vaccinated and for the fully vaccinated to get their boosters. In a news conference with Gov. Jim Justice and other state officials, Marsh said there have been no cases of the omicron variant identified yet in West Virginia but that state officials were on alert. There also have been no cases yet identified in…
Objectives To estimate age-specific abortion incidence and unintended pregnancy in Kinshasa, Democratic Republic of Congo and compare care experiences between adolescents (15 –19 years) and older women (20–49 years).Design We used the age-specific variant of the Abortion Incidence Complications Method to estimate abortion and unintended pregnancy, with data from three primary sources: Health Facility Survey (n=361) provided postabortion care (PAC) caseloads; Prospective Morbidity Survey (n=1031) provided the age distribution and characteristics of women presenting for PAC and Health Professional Survey (n=115) ...
The early years of the HIV/AIDS epidemic were “plagued by confusion, fear, isolation, and discrimination” against those infected or at high risk, the President of the UN General Assembly reminded a commemorative meeting on Tuesday marking World AIDS Day – 40 years after the first cases were reported.
CHICAGO - GE Healthcare is launching new products across a range of medica...Read more on AuntMinnie.comRelated Reading: Clinical evaluation begins on GE photon-counting CT scanner FDA clears GE Healthcare's x-ray AI for endotracheal tube placement GE to split up, creating independent GE Healthcare Protest hits GE Healthcare plant over vaccine mandate GE to expand command center software across Ore.
"I think it's going to be a material drop. I just don't know how much, because we need to wait for the data."WebMD Health News
N-acetylcysteine is a promising compound for protecting cells from DNA damag...Read more on AuntMinnie.comRelated Reading: Low-dose CT works just as well as standard to diagnose appendicitis Most radiologists willing to perform PET/CT in pregnant women Body position on x-ray affects radiation dose in children Can 3D-printed shields protect patients during radiation therapy? Antioxidant formula halves DNA damage from CT
More News: Adenoviruses | African Health | Allergy | Allergy & Immunology | Brain | Cancer & Oncology | Cardiology | Cardiovascular | Child Development | Children | Clinical Trials | Congo Health | Contracts | Department of Health | Ebola | Ebola Vaccine | Environmental Health | Epidemics | Epidemiology | Food and Drug Administration (FDA) | Funding | Genetics | Government | Grants | Guinea Health | Health Management | Heart | Hypertension | Infectious Diseases | International Medicine & Public Health | Ireland Health | Learning | Legislation | Marketing | National Institutes of Health (NIH) | Neurology | Neuroscience | Outbreaks | Oxford University | Pandemics | Pharmaceuticals | Pregnancy | Pulmonary Hypertension | Rwanda Health | Science | Sierra Leone Health | Study | Tropical Medicine | Uganda Health | Universities & Medical Training | Vaccines | Veterinary Vaccinations | WHO | Women